MICHAEL PETERSON: Open Payments
NPI 1144885575 · ROSEBURG, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 43 payments from 13 companies in 2025. Trend: 2023 $282 · 2024 $510 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $225 |
| AstraZeneca Pharmaceuticals LP | 5 | $78 |
| Novo Nordisk Inc | 4 | $75 |
| Edwards Lifesciences Corporation | 3 | $71 |
| Medtronic, Inc. | 2 | $53 |
| Actelion Pharmaceuticals US, Inc. | 1 | $40 |
| Alnylam Pharmaceuticals Inc. | 2 | $33 |
| Boston Scientific Corporation | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| ABIOMED | 1 | $21 |
Products named: LEQVIO, Wegovy, LOKELMA, SAPIEN 3 Ultra RESILIA, OPSYNVI, VENASEAL, AMVUTTRA, Varithena Administration Pack.
Industry payments across OR — which companies pay providers there.
